Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation

NCT03533101 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cytokine Release Syndrome
Stem Cell Transplant Complications

Interventions

DRUG: Tocilizumab

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez